Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in

Afsun Sahin1, Hayyam Kiratli, Gaye Guler Tezel

  • 1Department of Ophthalmology, Ocular Oncology Service, Hacettepe University School of Medicine, Ankara, Turkey.

Ophthalmic Research
|December 14, 2006
PubMed
Abstract

Insights

Vascular endothelial growth factor (VEGF)-A and matrix metalloproteinase (MMP)-9 are frequently expressed in iris and ciliary body melanomas. However, their presence, along with extravascular matrix patterns (EMPs), did not correlate with metastasis in these anterior uveal melanomas.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pathology

Background:

  • Anterior uveal melanomas, including iris and ciliary body melanomas, are rare ocular tumors.
  • Understanding the molecular markers associated with melanoma progression is crucial for predicting patient outcomes.

Purpose of the Study:

  • To evaluate the expression of vascular endothelial growth factor (VEGF)-A, matrix metalloproteinase (MMP)-9, and extravascular matrix patterns (EMPs) in iris and ciliary body melanomas.
  • To investigate the correlation between these markers and histopathological parameters, including metastasis.

Main Methods:

  • Immunohistochemical analysis of VEGF-A and MMP-9 expression in 18 iris and ciliary body melanoma tumors.
  • Assessment of EMPs and routine hematoxylin-eosin staining.
  • Analysis of histopathological features such as cell type, pigmentation, mitotic index, and sclera invasion.

Main Results:

  • VEGF-A and MMP-9 expression was detected in 66.7% and 72.3% of tumors, respectively.
  • Various EMPs were observed in 66.7% of tumors.
  • Only one patient developed metastasis during follow-up, and no significant correlation was found between VEGF-A, MMP-9, EMPs, and metastasis.

Conclusions:

  • VEGF-A and MMP-9 are commonly expressed in anterior uveal melanomas.
  • The expression of VEGF-A, MMP-9, and EMPs does not appear to be predictive of metastasis in these tumors.